Showing results (351-360 of 1,274) with videos related to

Sort By:
Pageof 128
Veterinary and Comparative Oncology|July 19, 2023
Clinical outcomes in cats with renal carcinoma undergoing nephrectomy: A retrospective studyShannon A Kenny, Matthew R Cook, Jennifer A Lenz, et al.
Veterinary and Comparative Oncology|January 27, 2019
Metastatic immune infiltrates correlate with those of the primary tumour in canine osteosarcomaSita S Withers, Daniel York, Jin W Choi, et al.
Veterinary and Comparative Oncology|January 27, 2019
Clinical features and outcome of dermal squamous cell carcinoma in 193 dogs (1987-2017)Jennifer L Willcox, Stanley L Marks, Yu Ueda, et al.
Veterinary and Comparative Oncology|February 6, 2019
Canine oral primary melanoma cells exhibit shift to mesenchymal phenotype and phagocytic behaviourFranziska Schmid, Daniela Brodesser, Martin Reifinger, et al.
Veterinary and Comparative Oncology|December 22, 2019
Ultrasound is a poor predictor of early or overt liver or spleen metastasis in dogs with high-risk mast cell tumoursEvi Pecceu, Juan Carlos Serra Varela, Ian Handel, et al.
Veterinary and Comparative Oncology|November 29, 2019
The adrenergic receptor antagonists propranolol and carvedilol decrease bone sarcoma cell viability and sustained carvedilol reduces clonogenic survival and increases radiosensitivity in canine osteosarcoma cellsMegan M Duckett, Shee Kwan Phung, Linh Nguyen, et al.
Veterinary and Comparative Oncology|January 18, 2020
Clinical features of canine nodal T-cell lymphomas classified as CD8+ or CD4-CD8- by flow cytometryLauren J Harris, Emily D Rout, Julia D Labadie, et al.
Veterinary and Comparative Oncology|February 4, 2020
Toceranib phosphate in the treatment of canine thyroid carcinoma: 42 cases (2009-2018)Sabina Sheppard-Olivares, Nora M Bello, Elizabeth Wood, et al.
Veterinary and Comparative Oncology|November 22, 2020
Plasma 25-hydroxyvitamin D and the inflammatory response in canine cancerNicole Weidner, Anthony J Mutsaers, J Paul Woods, et al.
Veterinary and Comparative Oncology|November 2, 2020
Are B-symptoms more reliable prognostic indicators than substage in canine nodal diffuse large B-cell lymphomaOndřej Škor, Ludmila Bicanová, Birgitt Wolfesberger, et al.
Pageof 128